One year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

Research output: Research - peer-reviewJournal article

  • K Reich
    K ReichDermatologikum Hamburg & Georg-August-University, Göttingen, Germany.
  • L Puig
    L Puig
  • C Paul
    C Paul
  • K Kragballe
    K KragballeDenmark
  • T Luger
    T Luger
  • J Lambert
    J Lambert
  • S Chimenti
    S Chimenti
  • G Girolomoni
    G Girolomoni
  • J-F Nicolas
    J-F Nicolas
  • E Rizova
    E Rizova
  • M Brunori
    M Brunori
  • S Mistry
    S Mistry
  • P Bergmans
    P Bergmans
  • J Barker
    J Barker
Original languageEnglish
JournalBritish Journal of Dermatology
StatePublished - 30 Sep 2013

See relations at Aarhus University Citationformats

ID: 69017971